Melanocortin Receptor Agonist

PT-141

Arousal, centrally activated.

A synthetic melanocortin-receptor agonist that acts on the central nervous system — supporting sexual desire and arousal in both men and women.

SubcutaneousNasalTroche
Classification
Melanocortin Receptor Agonist
Administration
Subcutaneous · Nasal · Troche
Form
Powder · Nasal · Troche
About

Sexual function, centrally.

A synthetic peptide that activates melanocortin receptors in the central nervous system — addressing sexual desire at the neural level.

Who this is for
  • Adults experiencing low libido or diminished sexual desire
  • Patients with hypoactive sexual desire disorder (HSDD)
  • Couples seeking neural-based sexual function support
Clinical benefits
1

Sexual Desire & Arousal

Activates central melanocortin pathways governing desire. Natural arousal patterns return.

2

Erectile Function Support

Improves erectile response through central signaling. Performance reliability improves.

3

Female Sexual Arousal Disorder

Indicated for HSDD — addresses neural basis of arousal. Desire and response often normalize.

4

Central, Not Vascular, Mechanism

Acts on the CNS rather than the vascular system. Works at the neural level rather than blood flow alone.

5

Flexible On-Demand Use

Designed for use ahead of activity, not daily dosing. Take only when needed, no daily commitment.

What to expect — patients often report
Prior · 60 min

Effects typically begin within an hour of dosing.

As needed

No daily commitment — used ahead of activity.

Consistent

Predictable response with proper timing.

The RENEWL Standard
  • Physician-supervised by Thomas Nabity, MD
  • 503A / 503B compounding pharmacy sourcing
  • Pre-protocol labs, body composition, and review
  • 30 / 60 / 90-day follow-up with companion support

Is PT-141 right for you?